Dendris supported by the region and Bpifrance for the automation of its solution.
New financing granted to Dendris in order to continue its development plan. "I am pleased to inform you of the agreement to support your company in its projects through a refundable advance of 207,000 euros, respectively financed by the Ministry of the Economy and...
In 2019, Dendris signs a partnership with LALLEMAND / UMR for the development of a biochip for diagnosis of ruminal fibrolytic activity.
Lallemand, world leader in the development, production and sale of yeasts, bacteria and derived ingredients, associated with UMR MEDIS (Digestive environment and health microbiology dependent on Inra and university) asked Dendris to develop a biochip for studying the...
Dendris receives award for excellence at European research and innovation program Horizon 2020
Dendris Gendiag project « Next GENeration of inn vitro DIAGnostic in clinical microbiology » was assessed as a high quality project.
Dendris at RICAI dec 16th & 17th 2019
DendrisChipRD is now CE IVD
Dendris was present from to the 29th ECCMID in Amsterdam (13-16 April 2019)
Dendris has published in DIAGNOSTICS
"Innovative DendrisChips® Technology for a Syndromic Approach of In Vitro Diagnosis: Application to the Respiratory Infectious Diseases" See publication
Dendris has published in SCIENCE CHINA Materials
"Multiplexing technology for in vitro diagnosis of pathogens: the key contribution of phosphorus dendrimers” by Jean Pierre Majoral View publication
Two new partner laboratories join Dendris in 2018
Since February 2018, Dendris has tested its device on two news partner pilot site, Gen-Bio Gravanches, in Clermont Ferrand and Biolab avenir in Toulouse.
Dendris will be present at Ricai on december 2018 17th and 18th
RICAI is a well known congress dedicated to infectious diseases. Dendris will present its molecular diagnosis devices on december 2018 17th and 18th at the palais des congress in Paris. http://www.ricai.fr